BioLargo, Inc.
BLGO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,347 | -$3,504 | -$5,132 | -$6,894 |
| Dep. & Amort. | $255 | $172 | $45 | $20 |
| Deferred Tax | $0 | $0 | $0 | $314 |
| Stock-Based Comp. | $2,063 | $2,519 | $2,071 | $1,872 |
| Change in WC | -$1,620 | -$1,828 | -$250 | $249 |
| Other Non-Cash | $443 | $173 | -$145 | $502 |
| Operating Cash Flow | -$3,206 | -$2,365 | -$2,762 | -$3,937 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,235 | -$478 | -$271 | -$34 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$82 | $0 | $0 | -$13 |
| Investing Cash Flow | -$1,317 | -$478 | -$271 | -$34 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $850 | $38 | $74 | -$37 |
| Stock Issued | $2,649 | $4,621 | $3,617 | $4,932 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$345 | -$242 | $0 | $0 |
| Other Fin. Act. | $1,284 | $4,621 | $4,107 | $4,268 |
| Financing Cash Flow | $4,438 | $4,659 | $3,956 | $4,231 |
| Forex Effect | $94 | -$128 | -$34 | -$14 |
| Net Chg. in Cash | $9 | $1,688 | $889 | $246 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,539 | $1,851 | $962 | $716 |
| End Cash | $3,548 | $3,539 | $1,851 | $962 |
| Free Cash Flow | -$4,441 | -$2,843 | -$3,033 | -$3,971 |